# Phase 4 breast cancer trials recruiting: 51 (November 2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 51 trials in phase 4 for breast cancer that are recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Recruiting Phase 4 breast cancer trials: 51 rows for $5, recruiting or not yet recruiting on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. The new rows each week by email, about 1 row a month: $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/recruiting/phase-4/breast-neoplasms

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 51
- Recruiting or not yet: 51
- Read on: November 19, 2026

## Trials

The 25 newest of 51, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| October 5, 2026 | NCT07859319 | Evaluation of the Efficacy and Acceptability of a Phytotherapy Combining Devil's Claw, Blackcurrant and Meadowsweet for the Management of... | Hospices Civils de Lyon | Phase 4 | Not yet recruiting | Hormone Therapy-induced Arthralgia, Phytotherapy, Symptom Management, Adjuvant Treatment, Patient Acceptability, Joint... | 105 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07859319) |
| September 3, 2026 | NCT07802847 | Innovative and Cooperative Pathway Integrating Oncogeriatric, Pharmaceutical and Pharmacological Follow-up in Elderly Patients. | Gustave Roussy, Cancer Campus, Grand Paris | Phase 4 | Not yet recruiting | Elderly, Breast Cancer, Lung Cancer, Prostate Cancer, Colon Cancer, Kidney Cancer, Sarcoma | 794 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07802847) |
| July 10, 2026 | NCT07695259 | Olaparib+Trastuzumab+Pertuzumab Neoadjuvant for Elderly HER2+ Breast Cancer | Sponsor not shown (see the record) | Phase 4 | Recruiting | Elderly Females, HER2 + Breast Cancer, Neoadjuvant Therapy | 45 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07695259) |
| June 5, 2026 | NCT07630948 | Adherence and Safety of Ribociclib Plus Aromatase Inhibitors in Patients With Early Stage, HR+ and HER2- Breast Cancer | Institute of Oncology Ljubljana | Phase 4 | Not yet recruiting | Breast Cancer, Adherence, Medication | 90 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07630948) |
| May 20, 2026 | NCT07600164 | Real-world Study of Pyrotinib-containing Regimens of Advanced HER2-positive Breast Cancer | Peking University People's Hospital | Phase 4 | Recruiting | HER2 + Breast Cancer, Advanced Breast Cancer | 500 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07600164) |
| May 20, 2026 | NCT07599137 | Abemaciclib Dose Escalation in Early High-Risk Breast Cancer Adjuvant Therapy | Peking University Cancer Hospital & Institute | Phase 4 | Not yet recruiting | HR+/HER2- Breast Cancer | 86 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07599137) |
| May 15, 2026 | NCT07589699 | Trastuzumab Rezetecan (T-DXh) in HER2+ Breast Cancer With Non-pCR After TCbHP | The First Affiliated Hospital with Nanjing Medical University | Phase 4 | Not yet recruiting | Breast Cancer, HER2-positive Breast Cancer, Early-stage Breast Cancer, Locally Advanced Breast Cancer | 59 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07589699) |
| May 13, 2026 | NCT07583134 | Impact of Propranolol Strategies on Myocardial Injury After Breast Cancer Surgery | Sponsor not shown (see the record) | Phase 4 | Not yet recruiting | Breast Cancer, Myocardial Injury After Noncardiac Surgery (MINS) | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07583134) |
| May 11, 2026 | NCT07578064 | A Randomized, Self-controlled Post-marketing Clinical Study on the Comparison of Shengbai Oral Liquid and Leucogen Tablets in the Treatment... | Sponsor not shown (see the record) | Phase 4 | Recruiting | Breast Cancer, Bone Marrow Suppression | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07578064) |
| March 24, 2026 | NCT07490509 | Pharmacokinetic Model of Abemaciclib: Correlation With Severe Diarrhea as the Primary Toxicity Endpoint in Patients With Localized Hormone... | Poitiers University Hospital | Phase 4 | Not yet recruiting | Abemaciclib, Abemaciclib-related Diarrhea, Breast Cancer | 235 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07490509) |
| February 27, 2026 | NCT07436663 | Comparative Study Between (SGLT-2i) and (DPP-4i) in the Prevention of DIC | Tanta University | Phase 4 | Recruiting | Breast Cancer | 150 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07436663) |
| January 15, 2026 | NCT07344974 | Hand and Foot Bath for Taxane-Induced Peripheral Neurotoxicity | Peking University Cancer Hospital & Institute | Phase 4 | Not yet recruiting | Breast Cancer | 78 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07344974) |
| December 30, 2025 | NCT07308717 | Gabapentin And Breast Surgery Decision Architecture Randomization Trial (GABS-DART) Protocol | Memorial Sloan Kettering Cancer Center | Phase 4 | Recruiting | Breast Cancer | 1,896 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07308717) |
| December 2, 2025 | NCT07257679 | Gentle Touch for Post-Mastectomy Lymphedema | I.R.C.C.S. Fondazione Santa Lucia | Phase 4 | Recruiting | Lymphedema, Breast Cancer | 36 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07257679) |
| December 2, 2025 | NCT07257484 | Tirzepatide's Role in Postmenopausal HR+ Breast Cancer Survivors | Weill Medical College of Cornell University | Phase 4 | Recruiting | Obesity (Disorder), Breast Cancer | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07257484) |
| November 28, 2025 | NCT07254221 | Rosuvastatin for Prevention of Anthracycline-induced Cardiac Dysfunction in Breast Cancer Patients | Shiraz University of Medical Sciences | Phase 4 | Not yet recruiting | Anthracycline-induced Cardiac Toxicity, Breast Cancer, Anthracycline Related Cardiotoxicity in Breast Cancer... | 400 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07254221) |
| November 28, 2025 | NCT07252726 | Evaluating Dose Timing (Morning vs Evening) of Endocrine-based Therapies in Metastatic Breast and Prostate Cancers | Ottawa Hospital Research Institute | Phase 4 | Recruiting | Metastatic Breast Cancer, Metastatic Prostate Cancer | 50 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07252726) |
| October 27, 2025 | NCT07220967 | A Study of Antibiotic Delivery to Prevent Infection After Breast Tissue Expander Placement | Memorial Sloan Kettering Cancer Center | Phase 4 | Recruiting | Breast Cancer | 392 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07220967) |
| September 26, 2025 | NCT07195344 | Study Aiming to Compare the Plasma Exposure of the Payload (Free-DXd) in Patients Treated by T-DXd for Locally Advanced or Metastatic... | Institut Claudius Regaud | Phase 4 | Recruiting | Locally Advanced or Metastatic Breast Cancers | 210 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07195344) |
| September 9, 2025 | NCT07162259 | Cohort Study on Sequential ADC Therapy in HR-positive/HER2-negative Advanced Breast Cancer | Sponsor not shown (see the record) | Phase 4 | Not yet recruiting | Breast Neoplasms | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07162259) |
| September 5, 2025 | NCT07158164 | DPYD Pharmacogenomics and Fluoropyrimidine (FP) Dose-Adjustment | Rutgers, The State University of New Jersey | Phase 4 | Recruiting | Colorectal Neoplasms, Breast Neoplasms, Head and Neck Neoplasms, Gastro-Intestinal Intraepithelial Neoplasia | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07158164) |
| July 30, 2025 | NCT07093931 | Efficacy and Safety of Lobaplatin and Carboplatin as Neoadjuvant Therapy in HER-2 Positive Breast Cancer | Shandong Cancer Hospital and Institute | Phase 4 | Not yet recruiting | Breast Cancer | 468 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07093931) |
| June 29, 2025 | NCT07042581 | A Study of Revaree Plus in People With Breast Cancer | Memorial Sloan Kettering Cancer Center | Phase 4 | Recruiting | Breast Cancer, Stage 0 Breast Cancer, Stage I Breast Cancer, Stage II Breast Cancer, Stage III Breast Cancer, Stage 0... | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07042581) |
| April 10, 2025 | NCT06920810 | Viscum Album for TNBC on Adjuvant Pembrolizumab | Ilsan Cha hospital | Phase 4 | Recruiting | Breast Cancer, Triple Negative Breast Cancer | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06920810) |
| January 16, 2025 | NCT06777537 | Neoadjuvant Chemotherapy with or Without Talniflumate for the Treatment of Breast Cancer | Shandong University | Phase 4 | Not yet recruiting | Breast Cancer | 200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06777537) |

## Sponsors with the most

| Sponsor | Trials |
| --- | --- |
| Fudan University | 4 |
| Ottawa Hospital Research Institute | 3 |
| Memorial Sloan Kettering Cancer Center | 3 |
| Second Affiliated Hospital, Zhejiang University, School of Medicine | 3 |
| Weill Medical College of Cornell University | 2 |
| Peking University Cancer Hospital & Institute | 2 |
| I.R.C.C.S. Fondazione Santa Lucia | 1 |
| [Hoffmann-La Roche](https://specstream.ai/data/clinical-trials/company/hoffmann-la-roche) | 1 |
| United States Naval Medical Center, Portsmouth | 1 |
| Shanghai Jiao Tong University School of Medicine | 1 |
| Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | 1 |
| Helwan University | 1 |
| Shengjing Hospital | 1 |
| Ilsan Cha hospital | 1 |
| University of Cincinnati | 1 |
| Poitiers University Hospital | 1 |
| Shandong University | 1 |
| The First Affiliated Hospital with Nanjing Medical University | 1 |
| Peking University People's Hospital | 1 |
| Institute of Oncology Ljubljana | 1 |
| City of Hope Medical Center | 1 |
| Institut Claudius Regaud | 1 |
| Gustave Roussy, Cancer Campus, Grand Paris | 1 |
| Shiraz University of Medical Sciences | 1 |
| Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 1 |

## By country

| Country | Trials |
| --- | --- |
| China | 14 |
| United States | 12 |
| Canada | 4 |
| South Korea | 4 |
| France | 4 |
| Italy | 3 |
| Germany | 3 |
| Egypt | 2 |
| Belgium | 1 |
| Denmark | 1 |
| Finland | 1 |
| Norway | 1 |
| Spain | 1 |
| United Kingdom | 1 |
| Slovenia | 1 |
| Iran | 1 |
| Brazil | 1 |
| Russia | 1 |
| Switzerland | 1 |
| Poland | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Electronic parts suppliers in the United States](https://specstream.ai/data/businesses/electronic-parts-suppliers/united-states)
- [Montessori schools in the United States](https://specstream.ai/data/businesses/montessori-schools/united-states)
- [Translation companies in the United States](https://specstream.ai/data/businesses/translation-companies/united-states)
- [College counseling companies in the United States](https://specstream.ai/data/businesses/college-counseling-companies/united-states)
- [Irrigation contractors in the United States](https://specstream.ai/data/businesses/irrigation-contractors/united-states)
- [Shared office spaces in the United States](https://specstream.ai/data/businesses/shared-office-spaces/united-states)
